Q3 2025 saw 8% revenue growth and 10% organic growth, with adjusted EBITDA up 3% and a 9.8% margin. M&A activity is set to accelerate as leverage normalizes, and GRCA integration is driving synergy and margin improvement. Organic growth is expected to stabilize at high single digits.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.